Freestone Grove Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Freestone Grove Partners's ACLS Position: Q1 2026 in Review
Freestone Grove Partners increased its Axcelis (ACLS) stake by 0.4% in Q1 2026, buying an estimated $2.48K and bringing the position to 7,017 shares worth $653K. The position accounts for ﹤0.01% of the portfolio, ranked #555.
Freestone Grove Partners first reported a position in ACLS in Q4 2025 and has held it in 2 quarters since. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Freestone Grove Partners held 7,017 shares of Axcelis worth $653K as of Q1 2026.
- Freestone Grove Partners bought 28 Axcelis shares in Q1 2026, an estimated $2.48K.
- Axcelis made up ﹤0.01% of Freestone Grove Partners's portfolio in Q1 2026, its #555 holding.
- Freestone Grove Partners first reported a position in Axcelis in Q4 2025 and has held it in 2 quarters since.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.